Abstract
MmpL3 belongs to the Resistance, Nodulation and Division (RND) superfamily whose role in mycobacteria is the formation of the outer membrane. Indeed, it has been shown that MmpL3 is associated with the export of mycolic acids in the form of trehalose monomycolates (TMM) to the periplasmic space or the outer membrane. In the last few years several whole cell-based screenings of compound libraries brought by a number of diverse chemical scaffolds active against M. tuberculosis (Mtb) that surprisingly share MmpL3 as target. The diverse identified pharmacophores owe important differences among each other, in fact while some of them display inhibitory activity against pathogens that are devoid of mycolic acids and are active against non-replicating Mtb bacilli, some others specifically target mycobacteria and do not kill non-replicating bacilli. The scope of this review is to provide the recent advances in MmpL3 inhibitor discovery with a special focus on structure activity relationship (SAR) studies in order to provide information that could help in developing novel membrane-active anti- TB agents. Moreover, this review will provide the most recent insights into the modes of action of the MmpL3 inhibitors.
Keywords: Anti-tubercular agents, Drug-target, Drug discovery, M. tuberculosis, MmpL3, Structure-Activity Relationship.
Mini-Reviews in Medicinal Chemistry
Title:MmpL3 Inhibitors: Diverse Chemical Scaffolds Inhibit the Same Target
Volume: 16 Issue: 16
Author(s): Giovanna Poce, Sara Consalvi and Mariangela Biava
Affiliation:
Keywords: Anti-tubercular agents, Drug-target, Drug discovery, M. tuberculosis, MmpL3, Structure-Activity Relationship.
Abstract: MmpL3 belongs to the Resistance, Nodulation and Division (RND) superfamily whose role in mycobacteria is the formation of the outer membrane. Indeed, it has been shown that MmpL3 is associated with the export of mycolic acids in the form of trehalose monomycolates (TMM) to the periplasmic space or the outer membrane. In the last few years several whole cell-based screenings of compound libraries brought by a number of diverse chemical scaffolds active against M. tuberculosis (Mtb) that surprisingly share MmpL3 as target. The diverse identified pharmacophores owe important differences among each other, in fact while some of them display inhibitory activity against pathogens that are devoid of mycolic acids and are active against non-replicating Mtb bacilli, some others specifically target mycobacteria and do not kill non-replicating bacilli. The scope of this review is to provide the recent advances in MmpL3 inhibitor discovery with a special focus on structure activity relationship (SAR) studies in order to provide information that could help in developing novel membrane-active anti- TB agents. Moreover, this review will provide the most recent insights into the modes of action of the MmpL3 inhibitors.
Export Options
About this article
Cite this article as:
Poce Giovanna, Consalvi Sara and Biava Mariangela, MmpL3 Inhibitors: Diverse Chemical Scaffolds Inhibit the Same Target, Mini-Reviews in Medicinal Chemistry 2016; 16 (16) . https://dx.doi.org/10.2174/1389557516666160118105319
DOI https://dx.doi.org/10.2174/1389557516666160118105319 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Drugs and mitochondria
Mitochondria play a central role in the life and death of cells. They are not merely the center for energy metabolism but are also the headquarters for different catabolic and anabolic processes, calcium fluxes, and various signaling pathways. Mitochondria maintain homeostasis in the cell by interacting with reactive oxygen-nitrogen species ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
RNA Interference-Based Therapeutics: New Strategies to Fight Infectious Disease
Infectious Disorders - Drug Targets Treatment Failure in Ventilator Associated Pneumonia
Current Respiratory Medicine Reviews Recent Developments in Particulate-Based Vaccines
Recent Patents on Drug Delivery & Formulation Modulation of Neutrophil Development and Homeostasis
Current Molecular Medicine Translational Multimodality Neuroimaging
Current Drug Targets Natural Immunity Boosters as Therapeutic Interventions in the Era of the COVID-19 Pandemic
Endocrine, Metabolic & Immune Disorders - Drug Targets Global and Local Ancestry and its Importance: A Review
Current Genomics Editorial (Thematic Issue: Recent Advances in the Structure-Based Drug Design and Discovery)
Current Topics in Medicinal Chemistry The Need to Consider Context in the Evaluation of Anti-infectious and Immunomodulatory Effects of Vitamin A and its Derivatives
Current Drug Targets Synthesis, Spectroscopic Characterization and Antimicrobial Activities of Benzoxazolone Derivatives
Medicinal Chemistry Synthesis and SAR Studies of Urea and Thiourea Derivatives of Gly/Pro Conjugated to Piperazine Analogue as Potential AGE Inhibitors
Protein & Peptide Letters Bis(2-aminoimidazolines) and Bisguanidines: Synthetic Approaches, Antiparasitic Activity and DNA Binding Properties
Current Medicinal Chemistry Multiple, Extensive Cardiac and Pulmonary Hydatid Cysts Managed by a Single-stage Surgical Removal: A Case Report
New Emirates Medical Journal Synthesis of Benzalacetophenone-based Isoxazoline and Isoxazole Derivatives
Current Organic Chemistry Advancement in Vaccinology: New Era in Formulation Strategies
Current Drug Therapy Editorial [ Infectious Diseases: What is in our future? ]
Infectious Disorders - Drug Targets Synthesis and Antimycobacterial Activity of 2-aryl-3-(arylmethyl)-1,3-thiazolidin-4-ones
Letters in Drug Design & Discovery Chemodiversity in Freshwater and Terrestrial Cyanobacteria – A Source for Drug Discovery
Current Drug Targets Nanoparticles vs Cancer: A Multifuncional Tool
Current Topics in Medicinal Chemistry The Molecular Mechanisms of Glucocorticoids-Mediated Neutrophil Survival
Current Drug Targets